Responses
Interstitial lung disease
Original article
Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis
Compose a Response to This Article
Other responses
No responses have been published for this article.